IPSC
NASDAQ · Biotechnology
Century Therapeutics Inc
$2.29
+0.00 (+0.00%)
Open$2.29
Previous Close$2.29
Day High$2.31
Day Low$2.18
52W High$3.04
52W Low$0.44
Volume—
Avg Volume651.0K
Market Cap428.54M
P/E Ratio—
EPS$-0.11
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,094.3% upside
Current
$2.29
$2.29
Target
$27.35
$27.35
$22.03
$27.35 avg
$42.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 236.01M | 24.41M | 24.82M |
| Net Income | -20,715,707 | -1,389,193 | -1,166,783 |
| Profit Margin | -8.8% | -5.7% | -4.7% |
| EBITDA | -8,421,019 | -1,777,503 | -1,974,923 |
| Free Cash Flow | — | -1,484,406 | -1,631,995 |
| Rev Growth | +175.9% | +22.2% | +16.0% |
| Debt/Equity | — | 0.27 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |